New Alzheimer's drug enters first human tests
NCT ID NCT07301502
Summary
This is a first-in-human study to check if a new drug called AK152 is safe and how it behaves in the body. It will involve 108 healthy volunteers and people with early Alzheimer's disease. The main goal is to find the right dose and understand side effects before testing if it helps control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Frist Affiliated Hospital of USTC
Hefei, Anhui, China
Conditions
Explore the condition pages connected to this study.